| 000 | 01488 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516214152.0 | ||
| 264 | 0 | _c20150207 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.12256 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGueorguieva, Ivelina | |
| 245 | 0 | 0 |
_aDefining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cMay 2014 |
||
| 300 |
_a796-807 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacokinetics |
| 650 | 0 | 4 |
_aQuinolines _xpharmacokinetics |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xantagonists & inhibitors |
| 700 | 1 | _aCleverly, Ann L | |
| 700 | 1 | _aStauber, Anja | |
| 700 | 1 | _aSada Pillay, N | |
| 700 | 1 | _aRodon, Jordi A | |
| 700 | 1 | _aMiles, Colin P | |
| 700 | 1 | _aYingling, Jonathan M | |
| 700 | 1 | _aLahn, Michael M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 77 _gno. 5 _gp. 796-807 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.12256 _zAvailable from publisher's website |
| 999 |
_c23862770 _d23862770 |
||